1 |
Oxygen
💬
| 1件: Oxygen Oxygen | 3件: Medical air Medical air; Nitrogen; Oxygen; | - | - | 13件: 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬 |
2 |
Glucose
💬
| 1件: D-glucose D-glucose | 2件: D-glucose D-glucose; Glucose; | - | - | 3件: 49 49, 86, 88 💬 |
3 |
Nitric oxide
💬
| 1件: Nitric Oxide Nitric Oxide | 3件: INOmax INOmax; Nitric Oxide; Nitrosyl; | - | - | 7件: 85 85, 86, 88, 210, 251, 294, 299 💬 |
4 |
Bosentan
💬
| 1件: Bosentan Bosentan | 2件: Bosentan Bosentan; TRACLEER; | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
5 |
Fludeoxyglucose F 18
💬
| 1件: Fludeoxyglucose Fludeoxyglucose | 1件: FLUDEOXYGLUCOSE FLUDEOXYGLUCOSE; | - | - | 3件: 84 84, 85, 88 💬 |
6 |
Treprostinil
💬
| 1件: Treprostinil Treprostinil | 4件: Remodulin Remodulin; Treprostinil; Treprostinilo; Tyvaso; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 6件: 51 51, 84, 85, 86, 88, 210 💬 |
7 |
Ambrisentan
💬
| 1件: Ambrisentan Ambrisentan | 3件: AMBRISENTAN AMBRISENTAN; Letairis; VOLIBRIS; | 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 51 51, 84, 85, 86, 88, 210, 211 💬 |
8 |
Atorvastatin
💬
| 1件: Atorvastatin Atorvastatin | 3件: Atorvastatin Atorvastatin; Atorvastatin calcium; Lipitor; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬 |
9 |
Bosentan
💬
| 1件: Bosentan Bosentan | 2件: Bosentan Bosentan; Tracleer; | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
10 |
Gadobenic acid
💬
| 1件: Gadobenic acid Gadobenic acid | 2件: Gadobenate Gadobenate; MultiHance; | - | - | 3件: 13 13, 86, 88 💬 |
11 |
Imatinib
💬
| 1件: Imatinib Imatinib | 4件: Gleevec Gleevec; GLIVEC; Imatinib; Imatinib Mesylate; | 3件: ABL1 ABL1, KIT, PDGFRA 💬 | 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
12 |
Potassium
💬
| 1件: Potassium Potassium | 1件: Potassium Potassium; | - | - | 13件: 36 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 💬 |
13 |
Warfarin
💬
| 1件: Warfarin Warfarin | 2件: Warfarin Warfarin; Warfarin Sodium; | 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 11件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬 |
14 |
Dapagliflozin
💬
| 1件: Dapagliflozin Dapagliflozin | 2件: Dapagliflozin Dapagliflozin; Forxiga; | 1件: SLC5A2 SLC5A2 💬 | 1件: 💬 | 7件: 19 19, 49, 66, 67, 86, 88, 222 💬 |
15 |
Riociguat
💬
| 1件: Riociguat Riociguat | 2件: ADEMPAS ADEMPAS; RIOCIGUAT; | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 6件: 51 51, 84, 86, 88, 225, 299 💬 |
16 |
Edoxaban
💬
| 1件: Edoxaban Edoxaban | 1件: Edoxaban Edoxaban; | 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 46 46, 88 💬 |
17 |
Selexipag
💬
| 1件: Selexipag Selexipag | 2件: SELEXIPAG SELEXIPAG; Uptravi; | 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 5件: 51 51, 70, 84, 86, 88 💬 |
18 |
Macitentan
💬
| 1件: Macitentan Macitentan | 2件: MACITENTAN MACITENTAN; Opsumit; | 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 85, 86, 88, 210 💬 |